Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on Varegacestat PK
NCT06677996Phase 1Completed
- Sponsor
- Immunome
- Start
- Nov 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of varegacestat in desmoid tumor, sponsored by Immunome. Primary endpoints: Area Under the Curve from time zero to the last measurable concentration up to 5 weeks, Area Under the Curve from time zero to infinity up to 5 weeks and 2 more. Started Nov 2024; status: completed.
02
Drugs
varegacestat
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT06677996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677996.